Kiniksa Pharmaceuticals International (KNSA) Other Working Capital Changes (2017 - 2026)

Kiniksa Pharmaceuticals International's Other Working Capital Changes history runs 8 years deep, the most recent figure standing at $6.8 million for Q1 2026.

• Quarterly Other Working Capital Changes rose 105.07% year-over-year to $6.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.2 million (up 521.88% YoY) and the FY2025 annual result came in at $16.7 million, up 47811.43% from the prior year.
• Other Working Capital Changes was $6.8 million for Q1 2026 at Kiniksa Pharmaceuticals International, up from $4.0 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $25.0 million in Q4 2025 and bottomed at -$14.7 million in Q3 2025.
• A 5-year average of $1.4 million and a median of $2.0 million in 2023 frame the typical range for Other Working Capital Changes.
• Annual changes were most pronounced in 2023 — Other Working Capital Changes tumbled 557.89% — and 2025, when it soared 14519.44%.
• Kiniksa Pharmaceuticals International's Other Working Capital Changes stood at $19000.0 in 2022, then tumbled by 557.89% to -$87000.0 in 2023, then sank by 59.77% to -$139000.0 in 2024, then soared by 2975.54% to $4.0 million in 2025, then jumped by 69.98% to $6.8 million in 2026.
• Business Quant data shows KNSA's Other Working Capital Changes at $6.8 million in Q1 2026, $4.0 million in Q4 2025, and $5.3 million in Q3 2025.